Selected Publication:
Fuchs, S; Rödel, C; Brunner, T; Iro, H; Niedobitek, G; Sauer, R; Grabenbauer, GG.
Patterns of failure following radiation with and without chemotherapy in patients with nasopharyngeal carcinoma.
Onkologie. 2003; 26(1):12-8
Doi: 10.1159/000069858
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Brunner Thomas Baptist
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- PURPOSE: Aim of this study was to retrospectively evaluate patterns of failure, results, and prognostic factors for patients with nasopharyngeal cancer (NPC) following radiotherapy (RT) with and without concurrent chemotherapy (RCT). PATIENTS AND METHODS: Between 1978 and 1999, a total of 101 patients with NPC were treated in our hospital, of whom 53 received external megavoltage RT alone with a median total dose of 76 Gy (1978-1988), and 48 patients had RCT (1989-1999). For RCT a combination of 5-FU and cisplatin was used together with a median total dose of 72 Gy. Patterns of relapse, survival rates and toxicity as well as prognostic factors were evaluated retrospectively. RESULTS: RCT was associated with a marked reduction in distant metastases: 6/48 (13%) vs. 17/53 (32%) after RT alone. Locoregional tumor persistence was only marginally lower with RCT: 10/48 (21%) vs. 17/53 (32%) following RT. Patients with RCT demonstrated a survival advantage compared to those with RT alone (5-year overall survival (OS): 64% vs. 44%, p = 0.1). OS, disease-specific survival and locoregional control rates were 53, 57, and 78% at 5 years and 47, 51 and 78% at 10 years, respectively. OS was significantly affected by histology (p = 0.007), the patients' age (p = 0.009) and gender (p = 0.01). CONCLUSION: This retrospective study provides further evidence that both reduction of distant metastasis and enhanced local tumor control by combined radiochemotherapy may be associated with improved survival rates in NPC compared to radiation alone. Concurrent RCT is therefore considered the preferable treatment option, however, confirmation in randomized trials is still warranted.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adolescent - administration & dosage
-
Adult - administration & dosage
-
Aged - administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols - adverse effects, therapeutic use
-
Carcinoma, Squamous Cell - drug therapy, mortality, pathology, radiotherapy
-
Cisplatin - administration & dosage, adverse effects
-
Combined Modality Therapy - administration & dosage
-
Female - administration & dosage
-
Fluorouracil - administration & dosage, adverse effects
-
Follow-Up Studies - administration & dosage
-
Humans - administration & dosage
-
Male - administration & dosage
-
Middle Aged - administration & dosage
-
Nasopharyngeal Neoplasms - drug therapy, mortality, pathology, radiotherapy
-
Neoplasm Staging - administration & dosage
-
Radiotherapy Dosage - administration & dosage
-
Radiotherapy, High-Energy - administration & dosage
-
Retrospective Studies - administration & dosage
-
Survival Rate - administration & dosage
-
Treatment Failure - administration & dosage
- Find related publications in this database (Keywords)
-
nasopharyngeal carcinoma
-
radiochemotherapy
-
patterns of failure